0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Amphotericin B for Injection Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-15F17167
Home | Market Reports | Health| Health Conditions
Global Amphotericin B for Injection Market Research Report 2024
BUY CHAPTERS

Global Amphotericin B for Injection Market Research Report 2026

Code: QYRE-Auto-15F17167
Report
2026-04-10
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Amphotericin B for Injection Market

The global Amphotericin B for Injection market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Amphotericin B for Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.
The North American market for Amphotericin B for Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Amphotericin B for Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Amphotericin B for Injection include Gilead Sciences, SPH New Asia Pharmaceuticals, North China Pharmaceutical, Cspc Holdings, Jemincare, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Amphotericin B for Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Amphotericin B for Injection. The Amphotericin B for Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Amphotericin B for Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Amphotericin B for Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Amphotericin B for Injection Market Report

Report Metric Details
Report Name Amphotericin B for Injection Market
Segment by Type
  • Common Formulation
  • Liposome Formulation
by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Gilead Sciences, SPH New Asia Pharmaceuticals, North China Pharmaceutical, Cspc Holdings, Jemincare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Amphotericin B for Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Amphotericin B for Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Amphotericin B for Injection Market report?

Ans: The main players in the Amphotericin B for Injection Market are Gilead Sciences, SPH New Asia Pharmaceuticals, North China Pharmaceutical, Cspc Holdings, Jemincare

What are the Application segmentation covered in the Amphotericin B for Injection Market report?

Ans: The Applications covered in the Amphotericin B for Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Amphotericin B for Injection Market report?

Ans: The Types covered in the Amphotericin B for Injection Market report are Common Formulation, Liposome Formulation

1 Amphotericin B for Injection Market Overview
1.1 Product Definition
1.2 Amphotericin B for Injection by Type
1.2.1 Global Amphotericin B for Injection Market Value by Type: 2025 vs 2032
1.2.2 Common Formulation
1.2.3 Liposome Formulation
1.3 Amphotericin B for Injection by Application
1.3.1 Global Amphotericin B for Injection Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Amphotericin B for Injection Market Size Estimates and Forecasts
1.4.1 Global Amphotericin B for Injection Revenue 2021–2032
1.4.2 Global Amphotericin B for Injection Sales 2021–2032
1.4.3 Global Amphotericin B for Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Amphotericin B for Injection Market Competition by Manufacturers
2.1 Global Amphotericin B for Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Amphotericin B for Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Amphotericin B for Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Amphotericin B for Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Amphotericin B for Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Amphotericin B for Injection, Product Types and Applications
2.7 Global Key Manufacturers of Amphotericin B for Injection, Date of Entry into the Industry
2.8 Global Amphotericin B for Injection Market Competitive Situation and Trends
2.8.1 Global Amphotericin B for Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Amphotericin B for Injection Players Market Share by Revenue
2.8.3 Global Amphotericin B for Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Amphotericin B for Injection Market Scenario by Region
3.1 Global Amphotericin B for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Amphotericin B for Injection Sales by Region: 2021–2032
3.2.1 Global Amphotericin B for Injection Sales by Region: 2021–2026
3.2.2 Global Amphotericin B for Injection Sales by Region: 2027–2032
3.3 Global Amphotericin B for Injection Revenue by Region: 2021–2032
3.3.1 Global Amphotericin B for Injection Revenue by Region: 2021–2026
3.3.2 Global Amphotericin B for Injection Revenue by Region: 2027–2032
3.4 North America Amphotericin B for Injection Market Facts & Figures by Country
3.4.1 North America Amphotericin B for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Amphotericin B for Injection Sales by Country (2021–2032)
3.4.3 North America Amphotericin B for Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Amphotericin B for Injection Market Facts & Figures by Country
3.5.1 Europe Amphotericin B for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Amphotericin B for Injection Sales by Country (2021–2032)
3.5.3 Europe Amphotericin B for Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amphotericin B for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Amphotericin B for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Amphotericin B for Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Amphotericin B for Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Amphotericin B for Injection Market Facts & Figures by Country
3.7.1 Latin America Amphotericin B for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Amphotericin B for Injection Sales by Country (2021–2032)
3.7.3 Latin America Amphotericin B for Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Amphotericin B for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Amphotericin B for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Amphotericin B for Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Amphotericin B for Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amphotericin B for Injection Sales by Type (2021–2032)
4.1.1 Global Amphotericin B for Injection Sales by Type (2021–2026)
4.1.2 Global Amphotericin B for Injection Sales by Type (2027–2032)
4.1.3 Global Amphotericin B for Injection Sales Market Share by Type (2021–2032)
4.2 Global Amphotericin B for Injection Revenue by Type (2021–2032)
4.2.1 Global Amphotericin B for Injection Revenue by Type (2021–2026)
4.2.2 Global Amphotericin B for Injection Revenue by Type (2027–2032)
4.2.3 Global Amphotericin B for Injection Revenue Market Share by Type (2021–2032)
4.3 Global Amphotericin B for Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Amphotericin B for Injection Sales by Application (2021–2032)
5.1.1 Global Amphotericin B for Injection Sales by Application (2021–2026)
5.1.2 Global Amphotericin B for Injection Sales by Application (2027–2032)
5.1.3 Global Amphotericin B for Injection Sales Market Share by Application (2021–2032)
5.2 Global Amphotericin B for Injection Revenue by Application (2021–2032)
5.2.1 Global Amphotericin B for Injection Revenue by Application (2021–2026)
5.2.2 Global Amphotericin B for Injection Revenue by Application (2027–2032)
5.2.3 Global Amphotericin B for Injection Revenue Market Share by Application (2021–2032)
5.3 Global Amphotericin B for Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Company Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Amphotericin B for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Gilead Sciences Amphotericin B for Injection Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 SPH New Asia Pharmaceuticals
6.2.1 SPH New Asia Pharmaceuticals Company Information
6.2.2 SPH New Asia Pharmaceuticals Description and Business Overview
6.2.3 SPH New Asia Pharmaceuticals Amphotericin B for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 SPH New Asia Pharmaceuticals Amphotericin B for Injection Product Portfolio
6.2.5 SPH New Asia Pharmaceuticals Recent Developments/Updates
6.3 North China Pharmaceutical
6.3.1 North China Pharmaceutical Company Information
6.3.2 North China Pharmaceutical Description and Business Overview
6.3.3 North China Pharmaceutical Amphotericin B for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 North China Pharmaceutical Amphotericin B for Injection Product Portfolio
6.3.5 North China Pharmaceutical Recent Developments/Updates
6.4 Cspc Holdings
6.4.1 Cspc Holdings Company Information
6.4.2 Cspc Holdings Description and Business Overview
6.4.3 Cspc Holdings Amphotericin B for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Cspc Holdings Amphotericin B for Injection Product Portfolio
6.4.5 Cspc Holdings Recent Developments/Updates
6.5 Jemincare
6.5.1 Jemincare Company Information
6.5.2 Jemincare Description and Business Overview
6.5.3 Jemincare Amphotericin B for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Jemincare Amphotericin B for Injection Product Portfolio
6.5.5 Jemincare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amphotericin B for Injection Industry Chain Analysis
7.2 Amphotericin B for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amphotericin B for Injection Production Mode & Process Analysis
7.4 Amphotericin B for Injection Sales and Marketing
7.4.1 Amphotericin B for Injection Sales Channels
7.4.2 Amphotericin B for Injection Distributors
7.5 Amphotericin B for Injection Customer Analysis
8 Amphotericin B for Injection Market Dynamics
8.1 Amphotericin B for Injection Industry Trends
8.2 Amphotericin B for Injection Market Drivers
8.3 Amphotericin B for Injection Market Challenges
8.4 Amphotericin B for Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Amphotericin B for Injection Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Amphotericin B for Injection Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Amphotericin B for Injection Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Amphotericin B for Injection Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Amphotericin B for Injection Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Amphotericin B for Injection Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Amphotericin B for Injection Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Amphotericin B for Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Amphotericin B for Injection, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Amphotericin B for Injection, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Amphotericin B for Injection, Product Types and Applications
 Table 12. Global Key Manufacturers of Amphotericin B for Injection, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Amphotericin B for Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Amphotericin B for Injection Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Amphotericin B for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Amphotericin B for Injection Sales by Region (K Units), 2021–2026
 Table 18. Global Amphotericin B for Injection Sales Market Share by Region (2021–2026)
 Table 19. Global Amphotericin B for Injection Sales by Region (K Units), 2027–2032
 Table 20. Global Amphotericin B for Injection Sales Market Share by Region (2027–2032)
 Table 21. Global Amphotericin B for Injection Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Amphotericin B for Injection Revenue Market Share by Region (2021–2026)
 Table 23. Global Amphotericin B for Injection Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Amphotericin B for Injection Revenue Market Share by Region (2027–2032)
 Table 25. North America Amphotericin B for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Amphotericin B for Injection Sales by Country (K Units), 2021–2026
 Table 27. North America Amphotericin B for Injection Sales by Country (K Units), 2027–2032
 Table 28. North America Amphotericin B for Injection Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Amphotericin B for Injection Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Amphotericin B for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Amphotericin B for Injection Sales by Country (K Units), 2021–2026
 Table 32. Europe Amphotericin B for Injection Sales by Country (K Units), 2027–2032
 Table 33. Europe Amphotericin B for Injection Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Amphotericin B for Injection Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Amphotericin B for Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Amphotericin B for Injection Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Amphotericin B for Injection Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Amphotericin B for Injection Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Amphotericin B for Injection Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Amphotericin B for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Amphotericin B for Injection Sales by Country (K Units), 2021–2026
 Table 42. Latin America Amphotericin B for Injection Sales by Country (K Units), 2027–2032
 Table 43. Latin America Amphotericin B for Injection Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Amphotericin B for Injection Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Amphotericin B for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Amphotericin B for Injection Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Amphotericin B for Injection Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Amphotericin B for Injection Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Amphotericin B for Injection Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Amphotericin B for Injection Sales (K Units) by Type (2021–2026)
 Table 51. Global Amphotericin B for Injection Sales (K Units) by Type (2027–2032)
 Table 52. Global Amphotericin B for Injection Sales Market Share by Type (2021–2026)
 Table 53. Global Amphotericin B for Injection Sales Market Share by Type (2027–2032)
 Table 54. Global Amphotericin B for Injection Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Amphotericin B for Injection Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Amphotericin B for Injection Revenue Market Share by Type (2021–2026)
 Table 57. Global Amphotericin B for Injection Revenue Market Share by Type (2027–2032)
 Table 58. Global Amphotericin B for Injection Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Amphotericin B for Injection Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Amphotericin B for Injection Sales (K Units) by Application (2021–2026)
 Table 61. Global Amphotericin B for Injection Sales (K Units) by Application (2027–2032)
 Table 62. Global Amphotericin B for Injection Sales Market Share by Application (2021–2026)
 Table 63. Global Amphotericin B for Injection Sales Market Share by Application (2027–2032)
 Table 64. Global Amphotericin B for Injection Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Amphotericin B for Injection Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Amphotericin B for Injection Revenue Market Share by Application (2021–2026)
 Table 67. Global Amphotericin B for Injection Revenue Market Share by Application (2027–2032)
 Table 68. Global Amphotericin B for Injection Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Amphotericin B for Injection Price (US$/Unit) by Application (2027–2032)
 Table 70. Gilead Sciences Company Information
 Table 71. Gilead Sciences Description and Business Overview
 Table 72. Gilead Sciences Amphotericin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Gilead Sciences Amphotericin B for Injection Product
 Table 74. Gilead Sciences Recent Developments/Updates
 Table 75. SPH New Asia Pharmaceuticals Company Information
 Table 76. SPH New Asia Pharmaceuticals Description and Business Overview
 Table 77. SPH New Asia Pharmaceuticals Amphotericin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. SPH New Asia Pharmaceuticals Amphotericin B for Injection Product
 Table 79. SPH New Asia Pharmaceuticals Recent Developments/Updates
 Table 80. North China Pharmaceutical Company Information
 Table 81. North China Pharmaceutical Description and Business Overview
 Table 82. North China Pharmaceutical Amphotericin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. North China Pharmaceutical Amphotericin B for Injection Product
 Table 84. North China Pharmaceutical Recent Developments/Updates
 Table 85. Cspc Holdings Company Information
 Table 86. Cspc Holdings Description and Business Overview
 Table 87. Cspc Holdings Amphotericin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Cspc Holdings Amphotericin B for Injection Product
 Table 89. Cspc Holdings Recent Developments/Updates
 Table 90. Jemincare Company Information
 Table 91. Jemincare Description and Business Overview
 Table 92. Jemincare Amphotericin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Jemincare Amphotericin B for Injection Product
 Table 94. Jemincare Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Amphotericin B for Injection Distributors List
 Table 98. Amphotericin B for Injection Customers List
 Table 99. Amphotericin B for Injection Market Trends
 Table 100. Amphotericin B for Injection Market Drivers
 Table 101. Amphotericin B for Injection Market Challenges
 Table 102. Amphotericin B for Injection Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Amphotericin B for Injection
 Figure 2. Global Amphotericin B for Injection Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Amphotericin B for Injection Market Share by Type: 2025 & 2032
 Figure 4. Common Formulation Product Picture
 Figure 5. Liposome Formulation Product Picture
 Figure 6. Global Amphotericin B for Injection Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Amphotericin B for Injection Market Share by Application: 2025 & 2032
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global Amphotericin B for Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Amphotericin B for Injection Market Size (US$ Million), 2021–2032
 Figure 13. Global Amphotericin B for Injection Sales (K Units), 2021–2032
 Figure 14. Global Amphotericin B for Injection Average Price (US$/Unit), 2021–2032
 Figure 15. Amphotericin B for Injection Report Years Considered
 Figure 16. Amphotericin B for Injection Sales Share by Manufacturers in 2025
 Figure 17. Global Amphotericin B for Injection Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Amphotericin B for Injection Players: Market Share by Revenue in Amphotericin B for Injection in 2025
 Figure 19. Amphotericin B for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Amphotericin B for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Amphotericin B for Injection Sales Market Share by Country (2021–2032)
 Figure 22. North America Amphotericin B for Injection Revenue Market Share by Country (2021–2032)
 Figure 23. United States Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Amphotericin B for Injection Sales Market Share by Country (2021–2032)
 Figure 26. Europe Amphotericin B for Injection Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Amphotericin B for Injection Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Amphotericin B for Injection Revenue Market Share by Region (2021–2032)
 Figure 34. China Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Amphotericin B for Injection Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Amphotericin B for Injection Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Amphotericin B for Injection Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Amphotericin B for Injection Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Amphotericin B for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Amphotericin B for Injection by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Amphotericin B for Injection by Type (2021–2032)
 Figure 54. Global Amphotericin B for Injection Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Amphotericin B for Injection by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Amphotericin B for Injection by Application (2021–2032)
 Figure 57. Global Amphotericin B for Injection Price (US$/Unit) by Application (2021–2032)
 Figure 58. Amphotericin B for Injection Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc